CStone Pharmaceuticals (HKG:2616)
Hong Kong · Delayed Price · Currency is HKD 5.92
+0.38 (6.86%)
At close: Feb 13, 2026
CStone Pharmaceuticals Market Cap
CStone Pharmaceuticals has a market cap or net worth of 8.16 billion as of February 13, 2026. Its market cap has increased by 161.89% in one year.
Market Cap
8.16B
Enterprise Value
7.83B
Revenue
221.89M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.92
Market Cap Chart
Since February 26, 2019, CStone Pharmaceuticals's market cap has decreased from 12.65B to 8.16B, a decrease of -35.54%. That is a compound annual growth rate of -6.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 8.16B | 5.13% |
| Dec 31, 2025 | 7.76B | 164.29% |
| Dec 31, 2024 | 2.94B | 1.52% |
| Dec 29, 2023 | 2.89B | -47.58% |
| Dec 30, 2022 | 5.52B | -42.71% |
| Dec 31, 2021 | 9.63B | -16.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 26, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Guangzhou Innogen Pharmaceutical Group | 12.49B |
| Nanjing Leads Biolabs | 12.09B |
| Shanghai Haohai Biological Technology | 10.95B |
| HBM Holdings | 9.85B |
| Abbisko Cayman | 8.81B |
| Alphamab Oncology | 8.62B |
| Lepu Biopharma | 8.32B |
| CK Life Sciences Int'l., (Holdings) | 7.98B |